Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer-Reference-Cited by-同舟云学术

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer

Published:2019-06-10 Issue:1 Volume:75 Page:128-136
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Peters Elke E M¹²^ORCID,Bartosch Carla³,McCluggage W Glenn⁴^ORCID,Genestie Catherine⁵,Lax Sigurd F⁶,Nout Remi⁷,Oosting Jan¹,Singh Naveena⁸^ORCID,Smit Huub C S H⁹,Smit Vincent T H B M¹,Van de Vijver Koen K⁹^ORCID,Bosse Tjalling¹

Affiliation:

1. Department of Pathology Leiden University Medical Center Leiden the Netherlands

2. Department of Pathology Haaglanden Medical Center The Hague the Netherlands

3. Department of Pathology Portuguese Oncology Institute‐Porto Porto Portugal

4. Department of Pathology Belfast Health and Social Care Trust Belfast Northern Ireland UK

5. Department of BioPathology University Paris‐Saclay, Gustave‐Roussy Cancer Center Villejuif France

6. Department of Pathology Hospital Graz II and Medical University of Graz Graz Austria

7. Department of Radiation Oncology Leiden University Medical Center Leiden the Netherlands

8. Department of Cellular Pathology Barts Health NHS Trust London UK

9. Department of Pathological Anatomy Ghent University Hospital Ghent Belgium

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13871

Reference42 articles.

1. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

2. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

3. Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis

4. A clinically applicable molecular-based classification for endometrial cancers

5. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 changes to FIGO endometrial cancer staging: Counterpoint;Gynecologic Oncology;2024-05

2. Prognosis of Stage I Endometrial Cancer According to the FIGO 2023 Classification Taking into Account Molecular Changes;Cancers;2024-01-17

3. Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma?;Gynecologic Oncology;2023-10

4. Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer;International Journal of Gynecologic Cancer;2023-09-04

5. FIGO staging of endometrial cancer: 2023;International Journal of Gynecology & Obstetrics;2023-06-20